B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants

Aim: Haemodynamically significant patent ductus arteriosus (hsPDA) is frequently observed in premature infants. This study was conducted to explore whether the blood BNP can be a valuable biomarker to assess the necessity of treatment for hsPDA in premature infants. Methods: Serial measurements of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mine, Kenji, Ohashi, Atsushi, Tsuji, Shoji, Nakashima, Jun-ichi, Hirabayashi, Masato, Kaneko, Kazunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798123/
https://www.ncbi.nlm.nih.gov/pubmed/23611593
http://dx.doi.org/10.1111/apa.12273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798123/
https://www.ncbi.nlm.nih.gov/pubmed/23611593
http://dx.doi.org/10.1111/apa.12273

Ejemplares similares